Real-time enrollment status for this clinically significant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:10 AM UTC
| NCT Number | NCT07492927 |
| Recruiting Status | Recruiting |
| Condition | Clinically Significant Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,700 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Xijing Hospital |
| Last Updated on CT.gov | March 25, 2026 (Mar 25, 2026) |
As of July 17, 2026: Clinical trial NCT07492927 is currently recruiting participants. This clinical trial study for clinically significant prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Xijing Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07492927 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07492927 was last updated Mar 25, 2026 (March 25, 2026). HelloStudys verifies this status automatically.